The PI3K/AKT/mTOR pathway, as a primary regulator of cell growth and survival, has been shown to promote tumor cell proliferation, inhibit apoptosis, and enhance drug resistance when aberrantly activated factors that are crucial in HCC progression (Fig. 5D). Here, AKT1 is linked to hepatocellular carcinoma.